EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predicting survival in glioblastoma with multimodal neuroimaging and machine learning

Patrick H Luckett, Michael Olufawo, Bidhan Lamichhane, Ki Yun Park, Donna Dierker, Gabriel Trevino Verastegui, Peter Yang, Albert H Kim, Milan G Chheda, Abraham Z Snyder, Joshua S Shimony, Eric C Leuthardt

Journal of Neuro-Oncology · 2023-09 · 164 (2) · 309-320

DOI: 10.1007/s11060-023-04439-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, online erschienen am 05.09.2023. Verfasst von Patrick H Luckett und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, 63110, USA. luckett.patrick@wustl.edu. Hauptthemen laut MEDLINE: Glioblastoma. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIBIB NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Glioblastoma (GBM) is the most common and aggressive malignant glioma, with an overall median survival of less than two years. The ability to predict survival before treatment in GBM patients would lead to improved disease management, clinical trial enrollment, and patient care.

Methods

GBM patients (N = 133, mean age 60.8 years, median survival 14.1 months, 57.9% male) were retrospectively recruited from the neurosurgery brain tumor service at Washington University Medical Center. All patients completed structural neuroimaging and resting state functional MRI (RS-fMRI) before surgery. Demographics, measures of cortical thickness (CT), and resting state functional network connectivity (FC) were used to train a deep neural network to classify patients based on survival (< 1y, 1-2y, >2y). Permutation feature importance identified the strongest predictors of survival based on the trained models.

Results

The models achieved a combined cross-validation and hold out accuracy of 90.6% in classifying survival (< 1y, 1-2y, >2y). The strongest demographic predictors were age at diagnosis and sex. The strongest CT predictors of survival included the superior temporal sulcus, parahippocampal gyrus, pericalcarine, pars triangularis, and middle temporal regions. The strongest FC features primarily involved dorsal and inferior somatomotor, visual, and cingulo-opercular networks.

Conclusion

We demonstrate that machine learning can accurately classify survival in GBM patients based on multimodal neuroimaging before any surgical or medical intervention. These results were achieved without information regarding presentation symptoms, treatments, postsurgical outcomes, or tumor genomic information. Our results suggest GBMs have a global effect on the brain’s structural and functional organization, which is predictive of survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaHumansMaleMiddle AgedFemaleRetrospective StudiesMagnetic Resonance ImagingNeuroimagingMachine Learning

Stichwörter der Autor:innen

Cortical thicknessDeep learningFunctional MRIGlioblastomaSurvival

Autor:innen und Institutionen

  • Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, 63110, USA. luckett.patrick@wustl.edu.
  • Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, 63110, USA.
  • Center for Health Sciences, Oklahoma State University, Tulsa, OK, 74136, USA.
  • Department of Neuroscience, Washington University School of Medicine, St. Louis, MO, 63110, USA.
  • Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
  • Brain Tumor Center at Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.

Förderung

  • NIA NIH HHS
  • NIBIB NIH HHS
  • NINDS NIH HHS
  • NCI NIH HHS
  • Washington University Yearlong Research Program Dean’s Fellowship
  • National Cancer Institute
  • National Institute of Neurological Disorders and Stroke
  • National Institute of Biomedical Imaging and Bioengineering

Zitieren

APA

Luckett, P. H., Olufawo, M., Lamichhane, B., Park, K. Y., Dierker, D., Verastegui, G. T., Yang, P., Kim, A. H., Chheda, M. G., Snyder, A. Z., Shimony, J. S., & Leuthardt, E. C. (2023). Predicting survival in glioblastoma with multimodal neuroimaging and machine learning. Journal of Neuro-Oncology, 164(2), 309-320. https://doi.org/10.1007/s11060-023-04439-8

Vancouver

Luckett PH, Olufawo M, Lamichhane B, Park KY, Dierker D, Verastegui GT, et al. Predicting survival in glioblastoma with multimodal neuroimaging and machine learning. Journal of Neuro-Oncology. 2023;164(2):309-320. doi:10.1007/s11060-023-04439-8

BibTeX
@article{Luckett2023,
  author = {Luckett, Patrick H and Olufawo, Michael and Lamichhane, Bidhan and Park, Ki Yun and Dierker, Donna and Verastegui, Gabriel Trevino and Yang, Peter and Kim, Albert H and Chheda, Milan G and Snyder, Abraham Z and Shimony, Joshua S and Leuthardt, Eric C},
  title = {Predicting survival in glioblastoma with multimodal neuroimaging and machine learning},
  journal = {Journal of Neuro-Oncology},
  year = {2023},
  volume = {164},
  number = {2},
  pages = {309--320},
  doi = {10.1007/s11060-023-04439-8}
}
Kostenlos starten →